My Genomics is a company founded in 2012 with the mission of promoting preventive healthcare tailored to individual genetic makeup. The company's slogan, "For about 99.9% you are equal to the rest of humans, but you own a 0.1% that makes you unique!" encapsulates its focus on leveraging genomics to provide personalized health insights. My Genomics stands out for its commitment to research and development, leading to the creation of GenoTest, state-of-the-art predictive genomic tests. Headquartered in San Marino, My Genomics boasts a team of industry experts, including managers, researchers, professors, and international laboratories. Their collaborative approach emphasizes empathy, assistance, and support, reflecting the company's dedication to individualized preventive care. With no disclosed recent investment information, My Genomics presents an intriguing opportunity for investors seeking to capitalize on the rapidly growing genomics and personalized healthcare market. The company's focus on innovation, personalized medicine, and a global perspective makes it a potentially lucrative prospect for venture capital firms looking to tap into the future of healthcare.
There is no investment information
No recent news or press coverage available for My Genomics.